Potential of graphene-based materials to combat COVID-19: properties, perspectives, and prospects. (December 2020)

• Record Type: Journal Article
• Authors: Srivastava, A.K.; Dwivedi, N.; Dhand, C.; Khan, R.; Sathish, N.; Gupta, M.K.; Kumar, R.; Kumar, S.
• Is Part Of: Materials today chemistry. Volume 18(2020)
• Publication Date: 2020-12
• Subjects: Materials -- Microbe -- Virus -- SARS-CoV-2; Chemistry -- Periodicals; Materials -- Research -- Periodicals; Materials science -- Periodicals; Chemistry; Materials -- Research; Electronic journals; Periodicals; 660.282
• DOI: 10.1016/j.mtchem.2020.100385
• Languages: English
• ISSNs: 2468-5194

Abstract

Abstract: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a new virus in the coronavirus family that causes coronavirus disease (COVID-19), emerges as a big threat to the human race. To date, there is no medicine and vaccine available for COVID-19 treatment. While the development of medicines and vaccines are essentially and urgently required, what is also extremely important is the repurposing of smart materials to design effective systems for combating COVID-19. Graphene and graphene-related materials (GRMs) exhibit extraordinary physicochemical, electrical, optical, antiviral, antimicrobial, and other fascinating properties that warrant them as potential candidates for designing and development of high-performance components and devices required for COVID-19 pandemic and other futuristic calamities. In this article, we discuss the potential of graphene and GRMs for healthcare applications and how they may contribute to fighting against COVID-19. Graphical abstract: Image 1 Highlights: Potential of graphene-based materials to combat viral diseases, and virus spread. The properties of graphene-based materials for healthcare applications. Various graphene-based biosensor technologies for the diagnosis of viruses. Graphene-based nanofoams and 3D printed components for protective equipment's. Graphene-based antiviral surface coatings for high touch surfaces.